The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Some stimulatory receptors of the innate immune system, such as the NKG2D receptor (also called KLRK1) expressed by natural killer cells and activated CD8(+)T cells, recognize self-molecules that are upregulated in diseased cells by poorly understood mechanisms. Here we show that mouse and human NKG2D ligands are upregulated in non-tumour cell lines by genotoxic stress and stalled DNA replication, conditions known to activate a major DNA damage checkpoint pathway initiated by ATM (ataxia telangiectasia, mutated) or ATR (ATM- and Rad3-related) protein kinases. Ligand upregulation was prevented by pharmacological or genetic inhibition of ATR, ATM or Chk1 (a downstream transducer kinase in the pathway). Furthermore, constitutive ligand expression by a tumour cell line was inhibited by targeting short interfering RNA to ATM, suggesting that ligand expression in established tumour cells, which often harbour genomic irregularities, may be due to chronic activation of the DNA damage response pathway. Thus, the DNA damage response, previously shown to arrest the cell cycle and enhance DNA repair functions, or to trigger apoptosis, may also participate in alerting the immune system to the presence of potentially dangerous cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In addition, genomic damage—a common cause of cellular senescence—induces expression of the membrane-bound ligands for the major natural killer cell receptor NKG2D (140).”
From Aging, Cellular Senescence, and Cancer (2013) · cites this paper as [140]
The cited source says what the claim attributes to it.
In the citing paper
“other evidence indicates that the immune system's recognition of tumour cells might require the continuous activation of the DDR pathway 13”
From The common biology of cancer and ageing (2007) · cites this paper as [13]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Further, DNA damage or activation of oncogenes can induce cellular senescence, through a pathway that relies, in part, on the secretion of pro-inflammatory cytokines such as insulin-like growth factor binding protein-7 (IGFBP7)32 and IL-633, and on the secretion of CXC-chemokine ligand 8 (CXCL8) and other chemokines 33,34, as well as on the expression of the CXCL8 receptor CXC-chemokine receptor 2”
From Immunogenic and tolerogenic cell death (2009) · cites this paper as [32]
Experimental — accuracy not yet measuredIn the citing paper
“These findings are consistent with previous studies suggesting that NKG2D ligands are induced by a variety of other stimuli, including E2F transcription factors, PI3 kinase, Ras oncogene signaling, and an activated DNA damage response (Gasser et al., 2005; Tokuyama et al., 2011; Jung et al., 2012).”
From p53-dependent chemokine production by senescent tumor cells supports NKG2D-dependent tumor elimination by natural killer cells (2013) · cites this paper as Gasser et al., 2005
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: p73α Regulation by Chk1 in Response to DNA Damage
Gonzalez, S., Prives, C., & Cordon-Cardo, C. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.22.8161-8171.2003 · Cited by 75
RetractedDNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation
Bakkenist, C. J., & Kastan, M. B. (2003) · Nature · doi:10.1038/nature01368 · Cited by 3,466
Molecular Mechanisms of Mammalian DNA Repair and the DNA Damage Checkpoints
Sancar, A., Lindsey-Boltz, L. A., Ünsal-Kaçmaz, K., & Linn, S. (2004) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.73.011303.073723 · Cited by 3,317
DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis
Bartkova, J., Hořejší, Z., Koed, K., Krämer, A., Tort, F., Zieger, K., Guldberg, P., Sehested, M., Nesland, J. M., Lukas, C., et al. (2005) · Nature · doi:10.1038/nature03482 · Cited by 2,688
Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions
Gorgoulis, V. G., Vassiliou, L.-V. F., Karakaidos, P., Zacharatos, P., Kotsinas, A., Liloglou, T., Venere, M., DiTullio, R. A., Kastrinakis, N. G., Levy, B., et al. (2005) · Nature · doi:10.1038/nature03485 · Cited by 2,009
Cell cycle checkpoint signaling through the ATM and ATR kinases
Abraham, R. T. (2001) · Genes & Development · doi:10.1101/gad.914401 · Cited by 1,966
Chk1 and Chk2 kinases in checkpoint control and cancer
Bartek, J., & Lukas, J. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00110-7 · Cited by 1,513
Roles of the NKG2D immunoreceptor and its ligands
Raulet, D. H. (2003) · Nature Reviews Immunology · doi:10.1038/nri1199 · Cited by 1,348
Self-citation(1999) · PubMed · Cited by 1,030
ATR disruption leads to chromosomal fragmentation and early embryonic lethality
Brown, E. J., & Baltimore, D. (2000) · Genes & Development · doi:10.1101/gad.14.4.397 · Cited by 951
Self-citation
Cited by
Items 201–300 of 1,000
Ward, J., Davis, Z., DeHart, J., Zimmerman, E., Bosque, A., Brunetta, E., Mavilio, D., Planelles, V., & Barker, E. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000613 · Cited by 141
“DNA damage leads to the expression of NKG2D ligands [29]; our observations here indicate that Vpr, through activation of the DNA damage pathway, induces similar effects as those reported by Gasser [29].”
BackgroundResultInfluentialSenescence and the tumor-immune landscape: Implications for cancer immunotherapy
Chibaya, L., Snyder, J. T., & Ruscetti, M. A. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.02.005 · Cited by 161
Natural killer cells in human autoimmune disorders
Fogel, L., Yokoyama, W., & French, A. R. (2013) · Arthritis Research & Therapy · doi:10.1186/ar4232 · Cited by 156
“Furthermore, the upregulation of NK cell activation ligands on host cells is limited in the absence of cellular stress or infection [20,21] to minimize inadvertent NK cell activation and host damage.”
BackgroundArdolino, M., Zingoni, A., Cerboni, C., Cecere, F., Soriani, A., Iannitto, M. L., & Santoni, A. (2011) · Blood · doi:10.1182/blood-2010-08-300954 · Cited by 163
Histone deacetylase inhibitors: potential targets responsible for their anti-cancer effect
Dickinson, M., Johnstone, R. W., & Prince, H. M. (2010) · Investigational New Drugs · doi:10.1007/s10637-010-9596-y · Cited by 144
“hydroxyurea, presumably by accentuation of the DNA damage response [152, 158, 159].”
BackgroundPateras, I. S., Havaki, S., Nikitopoulou, X., Vougas, K. N., Townsend, P. A., Panayiotidis, M. I., Georgakilas, A. G., & Gorgoulis, V. G. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.06.011 · Cited by 158
“Although previous studies described that p53 was not required for NKGDL upregulation (Gasser et al., 2005), two other studies demonstrated the presence of functional p53-responsive elements in ULBP1-2 (Textor et al.”
BackgroundInfluentialDNA damage and innate immunity: links and trade-offs
Chatzinikolaou, G., Karakasilioti, I., & Garinis, G. A. (2014) · Trends in Immunology · doi:10.1016/j.it.2014.06.003 · Cited by 158
The extended human leukocyte receptor complex: diverse ways of modulating immune responses
Barrow, A. D., & Trowsdale, J. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00653.x · Cited by 165
Salicylic Acid Activates DNA Damage Responses to Potentiate Plant Immunity
Yan, S., Wang, W., Marqués, J., Mohan, R., Saleh, A., Durrant, W. E., Song, J., & Dong, X. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.09.019 · Cited by 157
“In animals, it has also been shown that DNA-damaging treatment can activate the immune systems (Gasser et al., 2005; Menendez et al., 2011).”
BackgroundTumor-Derived Extracellular Vesicles Inhibit Natural Killer Cell Function in Pancreatic Cancer
Zhao, J., Schlößer, H., Wang, Z., Qin, J., Li, J., Popp, F., Popp, M. C., Alakus, H., Chon, S., Hansen, H. P., et al. (2019) · Cancers · doi:10.3390/cancers11060874 · Cited by 148
“The stress proteins MICA and MICB are widely expressed by cancer cells due to genomic damage [37].”
BackgroundDendritic Cells, the T-cell-inflamed Tumor Microenvironment, and Immunotherapy Treatment Response
Garris, C. S., & Luke, J. J. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-1321 · Cited by 137
“Oncogene influence on NK-cell responses is not well described, although DNA damage responses within tumors are also known to upregulate NKactivating ligands, suggesting that tumor intrinsic features could drive NK activation and recruitment (51).”
BackgroundTRF2 inhibits a cell-extrinsic pathway through which natural killer cells eliminate cancer cells
Biroccio, A., Cherfils‐Vicini, J., Augereau, A., Pinte, S., Bauwens, S., Ye, J., Simonet, T., Horard, B., Jamet, K., Cervera, L., et al. (2013) · Nature Cell Biology · doi:10.1038/ncb2774 · Cited by 150
Boutet, P., Agüera‐González, S., Atkinson, S. J., Pennington, C. J., Edwards, D. R., Murphy, G., Reyburn, H. T., & Valés‐Gómez, M. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.1.49 · Cited by 146
“The vast majority of healthy cells do not express MIC molecules and instead their expression at the cell surface is up-regulated in pathological situations like cancer and autoimmunity; so, broadly, MICA/B expression is related to stress, although much remains unclear about the molecular mechanisms regulating their ex…”
BackgroundMincheva‐Nilsson, L., & Baranov, V. I. (2014) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2014.02.010 · Cited by 146
Recent developments in immunotherapy for gastrointestinal tract cancers
Chong, X., Madeti, Y., Cai, J., Li, W., Cong, L., Lu, J., Mo, L., Liu, H., He, S., Yu, C., et al. (2024) · Journal of Hematology & Oncology · doi:10.1186/s13045-024-01578-x · Cited by 147
Cerboni, C., Fionda, C., Soriani, A., Zingoni, A., Doria, M., Cippitelli, M., & Santoni, A. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00508 · Cited by 136
“Gasser and colleagues ruled out p53 from the mechanisms at the basis of genotoxic drug-induced NKG2D ligand up-regulation in mice and human cell lines, since the lack of p53 had no effect on NKG2D ligand expression after genotoxic stress (11).”
InfluentialElsner, L., Muppala, V., Gehrmann, M., Lozano, J., Malzahn, D., Bickeböller, H., Brunner, E., Zientkowska, M., Herrmann, T., Walter, L., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.8.5523 · Cited by 140
“These NKG2D ligands appear to be up-regulated in response to stress (21, 22, 47, 48), and they signal the FIGURE 6.”
BackgroundResultTarakanova, V. L., Leung‐Pineda, V., Hwang, S., Yang, C.-W., Matatall, K. A., Basson, M., Sun, R., Piwnica-Worms, H. M., Sleckman, B. P., & Virgin, H. W. (2007) · Cell Host & Microbe · doi:10.1016/j.chom.2007.05.008 · Cited by 156
“DNA damage pathway activation upregulates ligands for the NKG2D receptor expressed by natural killer cells and activated CD8+ T cells (Gasser et al., 2005).”
BackgroundNKG2D signaling in cancer immunosurveillance
López‐Soto, A., Huergo-Zapico, L., Acebes‐Huerta, A., Villa-Álvarez, M., & Gonzalez, S. R. (2014) · International Journal of Cancer · doi:10.1002/ijc.28775 · Cited by 148
“Specifically, different means of inducing genotoxic stress were found to stimulate NKG2DL expression in a mechanism dependent on ataxia–telangiectasia mutated (ATM) or ATM- and Rad3related (ATR) master checkpoint kinases and independent of p53 activity.(53) However, further studies found that forced expression or phar…”
BackgroundThe role of the NKG2D receptor for tumor immunity
Coudert, J. D., & Held, W. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2006.07.008 · Cited by 150
“Rather, DNA damage, induced by ionizing radiation r alkylating agents, up-regulated NKG2D ligands in primary ouse lymphoid cells (Rae-1, MULT-1) and human fibroblasts MICA, ULBPs) [82].”
InfluentialCui, Y., & Guo, G. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17111942 · Cited by 133
“Besides myeloid cells, NK cells potentially can be activated by DNA damage-induced upregulation of UL16 binding protein 2 (ULBP2), a natural killer group 2D (NKG2D) ligand, which greatly enhance NK-mediated tumor elimination [117–121].”
BackgroundUnleashing Natural Killer Cells in the Tumor Microenvironment–The Next Generation of Immunotherapy?
Ben‐Shmuel, A., Biber, G., & Barda‐Saad, M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00275 · Cited by 147
“, Tregs, tumor associated macrophages, and MDSCs) (76–78), and sustained chronic activation (such as sustained activation through the activating NKG2D receptor) (79, 80).”
BackgroundHoldenrieder, S., Stieber, P., Peterfi, A., Nagel, D., Steinle, A., & Salih, H. R. (2006) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-006-0167-1 · Cited by 152
“The NKG2D ligands (NKG2DL), MICA and MICB, have been shown to be induced by genotoxic stress which is associated with malignant transformation [3].”
BackgroundSenescent cells: Living or dying is a matter of NK cells
Antonangeli, F., Zingoni, A., Soriani, A., & Santoni, A. (2019) · Journal of Leukocyte Biology · doi:10.1002/jlb.mr0718-299r · Cited by 129
Ostberg, J. R., Dayanç, B. E., Yuan, M., Oflazoglu, E., & Repasky, E. A. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.1106699 · Cited by 138
“Up-regulation of the NKG2D ligand MICA has been reported previously to occur upon more severe stresses such as heat shock ( 42°C) [26], bacterial or viral infection [42, 44, 45], DNA damage [46], oxidative stress [47], and treatment with retinoic acid [48] or the histone deacetylase inhibitor sodium valproate [49].”
BackgroundMartinet, L., Jean, C., Dietrich, G., Fournié, J., & Poupot, R. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.05.002 · Cited by 147
NKG2D ligands are expressed on stressed human airway epithelial cells
Borchers, M. T., Harris, N. L., Wesselkamper, S. C., Vitucci, M., & Cosman, D. (2006) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00327.2005 · Cited by 133
Natural Killer Cell Response to Chemotherapy-Stressed Cancer Cells: Role in Tumor Immunosurveillance
Zingoni, A., Fionda, C., Borrelli, C., Cippitelli, M., Santoni, A., & Soriani, A. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01194 · Cited by 125
“On the other hand, a different pathway governing NKG2DLs expression by chemicals known to induce genotoxic stress has been character ized in murine lymphoma cells: DDR drives to the presence of cytosolic DNA and to STING/TBK1dependent activation of the transcription factor IRF3, responsible for the upregulation of RAE…”
BackgroundInfluentialThe DNA damage response, immunity and cancer
Gasser, S., & Raulet, D. H. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2006.07.004 · Cited by 136
“Direct evidence for such a role of the DNA damage response as provided by our finding that DNA damaging agents or DNA eplication inhibitors, but not other common forms of stress, nduce expression of cell surface protein ligands for the NKG2D eceptor in an ATM or ATR dependent fashion [3].”
BackgroundInfluentialSelf-citationHanna, J. H., & Mandelboim, O. (2007) · Trends in Immunology · doi:10.1016/j.it.2007.03.005 · Cited by 135
Immunological Microenvironment of Hepatocellular Carcinoma and Its Clinical Implication
Nishida, N., & Kudo, M. (2017) · Oncology · doi:10.1159/000451015 · Cited by 131
Replication Stress, DNA Damage, Inflammatory Cytokines and Innate Immune Response
Ragu, S., Matos-Rodrigues, G. E., & López, B. S. (2020) · Genes · doi:10.3390/genes11040409 · Cited by 143
“The DNA damage sensor kinases ATM and ATR, as well as the downstream checkpoint kinase CHK1, were implicated in NKG2DL induction [33].”
BackgroundNatural killer cells: diversity in search of a niche
Santo, J. P. D. (2008) · Nature Immunology · doi:10.1038/ni.f.201 · Cited by 134
“, and genotoxic stress can upregulate NKG2D ligands by way of the DNA damage pathwa”
BackgroundNKG2D in NK and T Cell-Mediated Immunity
Ogasawara, K., & Lanier, L. L. (2005) · Journal of Clinical Immunology · doi:10.1007/s10875-005-8786-4 · Cited by 138
“In addition, recent studies have shown that the RAE-1 and UPBP genes can be induced by the pathways involved in cellular responses to DNA damage (34).”
Kim, H. S., Das, A., Gross, C. C., Bryceson, Y. T., & Long, E. O. (2010) · Immunity · doi:10.1016/j.immuni.2010.02.004 · Cited by 124
The NKG2D receptor: sensing stressed cells
López‐Larrea, C., Suárez-Álvarez, B., López‐Soto, A., López‐Vázquez, A., & Gonzalez, S. R. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2008.02.004 · Cited by 128
B7-H6/NKp30 interaction: a mechanism of alerting NK cells against tumors
Kaifu, T., Escalière, B., Gastinel, L. N., Vivier, É., & Baratin, M. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0802-7 · Cited by 138
“For example, genotoxic stress was shown to up-regulate NKG2D ligands on non-tumor cell lines, whereas interfering with the DNA damage pathway in tumor cells inhibited their constitutive expression [39].”
Distinct Requirements of MicroRNAs in NK Cell Activation, Survival, and Function
Bezman, N., Cedars, E., Steiner, D. F., Blelloch, R. H., Hesslein, D. G. T., & Lanier, L. L. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000980 · Cited by 134
The Tumor-Immune Microenvironment and Response to Radiation Therapy
Shiao, S. L., & Coussens, L. M. (2010) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-010-9194-9 · Cited by 125
“Examination of tumor cells exposed to ionizing radiation in vitro indicates that RT induces expression of NKG2D ligands, an activating receptor for NK cells [97, 98].”
BackgroundFrom CAR-T Cells to CAR-NK Cells: A Developing Immunotherapy Method for Hematological Malignancies
Lü, H., Zhao, X., Li, Z., Hu, Y., & Wang, H. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.720501 · Cited by 138
Use of NK cell activity in cure by transplant
Leung, W. H. (2011) · British Journal of Haematology · doi:10.1111/j.1365-2141.2011.08823.x · Cited by 138
“…example, NK cell therapy may be performed together with leukaemia-antigen specific antibody to mediate ADCC, cytokine treatment to improve effector function, or chemotherapy and radiation therapy that increase NKG2D ligand expression to facilitate ‘stressed-self’ recognition (Gasser et al, 2005).”
BackgroundGenetics, genomics, and evolutionary biology of NKG 2D ligands
Carapito, R., & Bahram, S. (2015) · Immunological Reviews · doi:10.1111/imr.12328 · Cited by 130
“In all cases, the DNA damage pathway is central in the regulation of NKG2DLs (112).”
BackgroundNKG2D-Dependent Antitumor Effects of Chemotherapy and Radiotherapy against Glioblastoma
Weiß, T., Schneider, H., Silginer, M., Steinle, A., Pruschy, M. N., Polić, B., Weller, M., & Roth, P. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-1766 · Cited by 127
“S3G), which supports the concept that the DNA-damage response is one stimulus for the induction of NKG2DL (56).”
BackgroundDDR-mediated crosstalk between DNA-damaged cells and their microenvironment
Malaquin, N., Carrier-Leclerc, A., Dessureault, M., & Rodier, F. (2015) · Frontiers in Genetics · doi:10.3389/fgene.2015.00094 · Cited by 113
“For example, some DDR regulated cell surface molecules can subsequently engage surrounding immune cells (NKG2D ligands) or can influence damaged cells survival (DR5 receptor) via receptor-ligand engagement (Wu et al., 1997; Finnberg et al., 2005; Gasser et al., 2005; Lam et al., 2014).”
BackgroundInfluentialKloss, M., Decker, P., Baltz, K. M., Baessler, T., Jung, G., Rammensee, H.-G., Steinle, A., Krusch, M., & Salih, H. R. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.10.6711 · Cited by 118
“Therefore it is the current conception that NKG2DL are usually not expressed on healthy tissue but rather are induced upon cellular stress like viral infection or genotoxic stress during malignant transformation (37, 38).”
BackgroundThe immunogenicity of tumor cell death
Kepp, O., Tesnière, A., Zitvogel, L., & Kroemer, G. (2008) · Current Opinion in Oncology · doi:10.1097/cco.0b013e32831bc375 · Cited by 130
Jung, H., Hsiung, B., Pestal, K., Procyk, E., & Raulet, D. H. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20120565 · Cited by 123
Self-citationKahraman, A., Schlattjan, M., Kocabayoglu, P., Yildiz-Meziletoglu, S., Schlensak, M., Fingas, C. D., Wedemeyer, I., Marquitan, G., Gieseler, R. K., Baba, H. A., et al. (2010) · Hepatology · doi:10.1002/hep.23253 · Cited by 116
New prospects on the NKG2D/NKG2DL system for oncology
Ullrich, E., Koch, J., Cerwenka, A., & Steinle, A. (2013) · OncoImmunology · doi:10.4161/onci.26097 · Cited by 127
“In 2005, Raulet and colleagues identified the DNA damage response mediated by the ataxia telangiectasia mutated (ATM) and (ataxia telangiectasia- and Rad3-related) ATR protein kinases as a key mechanism for the upregulation of NKG2DL on mouse and human tumor cells.(38) Subsequently, human NKG2DLs were detected on cell…”
Zafirova, B., Mandarić, S., Antulov, R., Krmpotić, A., Jonsson, H., Yokoyama, W. M., Jonjić, S., & Polić, B. (2009) · Immunity · doi:10.1016/j.immuni.2009.06.017 · Cited by 120
“NKG2D also senses cells expressing NKG2D ligands induced by the DNA-damage response pathway (Gasser et al., 2005).”
BackgroundMcSharry, B. P., Burgert, H.-G., Owen, D. P., Stanton, R. J., Prod’homme, V., Sester, M., Koebernick, K., Groh, V., Spies, T. A., Cox, S. T., et al. (2008) · Journal of Virology · doi:10.1128/jvi.02251-07 · Cited by 121
“NKG2DLs has been reported to occur in response to stress, including infection, genotoxic stimuli, cell transformation, and heat shock ( 22 , 23).”
BackgroundDressel, R., Schindehütte, J., Kuhlmann, T., Elsner, L., Novota, P., Baier, P. C., Schillert, A., Bickeböller, H., Herrmann, T., Trenkwalder, C., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002622 · Cited by 119
“These ligands are not expressed normally but they can become induced in response to stress, such as heat shock [44], virus infection [45], or genotoxic stress [46].”
BackgroundReal and artificial immune systems: computing the state of the body
Cohen, I. R. (2007) · Nature reviews. Immunology · doi:10.1038/nri2102 · Cited by 119
“Ligands for the NKG2D receptor are also upregulated in cells that have suffered damage to their DNA; thus, NK cells can be alerted to kill potentially dangerous body cells according to the stressed state of their DN”
BackgroundCellular senescence: hot or what?
Evan, G. I., & di Fagagna, F. D. (2009) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2008.11.009 · Cited by 151
“There is precedent for such an interaction: ligands of receptors of the innate immunity systems are induced by DNA damage through the involvement of DDR genes [63] and components of the innate antiviral defense have been shown to both modulate DDR signaling and interferons induction [64,65].”
BackgroundEpigenetic regulation of immune escape genes in cancer
Tomasi, T. B., Magner, W. J., & Khan, A. N. H. (2006) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-006-0164-4 · Cited by 146
“The ATM/ATR DNA damage pathway also induces NKG2D ligands (NKG2DL) in cancer cells [147] and could, by directly activating NK and CD8+ T cells, be an important component in early tumor immunity.”
BackgroundInfluentialImmune modulation by hypofractionated stereotactic radiation therapy: Therapeutic implications
Popp, I., Grosu, A., Niedermann, G., & Duda, D. G. (2016) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2016.07.013 · Cited by 119
“In addition, the NKG2D transmembrane protein expressed by NK cells, which is mainly responsible for the recognition of signals from CD8 + T cells and for the activation of cytotoxicity, can increasingly recognize cells affected by DNA damage after radiotherapy [32].”
BackgroundGirart, M. V., Fuertes, M. B., Domaica, C. I., Rossi, L. E., & Zwirner, N. W. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.6.3472 · Cited by 131
“cell activation (11, 12), or during the DNA damage response (13).”
BackgroundEpithelial–Mesenchymal Transition Induces an Antitumor Immune Response Mediated by NKG2D Receptor
López-Soto, A., Huergo-Zapico, L., Galván, J. A., Rodrigo, L., de Herreros, A. G., Astudillo, A., & Gonzalez, S. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202950 · Cited by 111
“NKG2D response may protect the host in the first stages of tumor development, at least in part, because activation of ataxia telangiectasia mutated pathway upregulates NKG2DL expression in malignant cells (14, 15).”
BackgroundCancer metastasis as a non-healing wound
Deyell, M., Garris, C. S., & Laughney, A. M. (2021) · British Journal of Cancer · doi:10.1038/s41416-021-01309-w · Cited by 113
“Although NKG2D ligands are typically upregulated in non-tumour cells by genotoxic stress and stalled DNA replication, it remains unclear whether NK activating ligands are regulated by genomic instability.(64) Interactions between other NK activating and inhibitory ligands have been extensively reviewed.”
BackgroundSystemic DNA damage responses in aging and diseases
Ribezzo, F., Shiloh, Y., & Schumacher, B. (2016) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.12.005 · Cited by 116
“This was tested in several murine tumor cell lines and showed as a consequence a decrease in the RAE1 levels [117].”
Five Layers of Receptor Signaling in γδ T-Cell Differentiation and Activation
Ribeiro, S. T., Ribot, J. C., & Silva-Santos, B. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00015 · Cited by 116
“NKG2D ligands are induced upon cellular stress, for example, downstream of the DNA-damage response pathway in tumor cells (111, 112).”
BackgroundStrowig, T., Chijioke, O., Carrega, P., Arrey, F., Meixlsperger, S., Rämer, P. C., Ferlazzo, G., & Münz, C. (2010) · Blood · doi:10.1182/blood-2010-02-270678 · Cited by 129
Blockade of NKG2D on NKT cells prevents hepatitis and the acute immune response to hepatitis B virus
Vilarinho, S., Ogasawara, K., Nishimura, S., Lanier, L. L., & Baron, J. L. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708968104 · Cited by 114
Chitinase enzyme activity in CSF is a powerful biomarker of Alzheimer disease
Watabe-Rudolph, M., Song, Z., Lausser, L., Schnack, C., Begus-Nahrmann, Y., Scheithauer, M.-O., Rettinger, G., Otto, M., Tumani, H., Thal, D. R., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e318247caa1 · Cited by 116
Key mechanisms involved in ionizing radiation-induced systemic effects. A current review
Mavragani, I. V., Laskaratou, D., Frey, B., Candéias, S. M., Gaipl, U. S., Lumniczky, K., & Georgakilas, A. G. (2015) · Toxicology Research · doi:10.1039/c5tx00222b · Cited by 123
Song, J., & Bent, A. F. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004030 · Cited by 119
“DNA damage response induces expression of innate immune system ligands of the NKG2D receptor [80].”
BackgroundNK Cells: Immune Cross-Talk and Therapeutic Implications
Malhotra, A., & Shanker, A. (2011) · Immunotherapy · doi:10.2217/imt.11.102 · Cited by 113
Immunosurveillance and immunotherapy of tumors by innate immune cells
Iannello, A., Thompson, T. W., Ardolino, M., Marcus, A., & Raulet, D. H. (2016) · Current Opinion in Immunology · doi:10.1016/j.coi.2015.11.001 · Cited by 105
“Regulation at the mRNA level The DNA damage response (DDR) pathway is an important mode of regulat largely post-transcriptionally [32,63,64].”
BackgroundSelf-citationExpression and function of NKG2D in CD4+ T cells specific for human cytomegalovirus
Sáez‐Borderías, A., Gumá, M., Angulo, A., Bellosillo, B., Pende, D., & López‐Botet, M. (2006) · European Journal of Immunology · doi:10.1002/eji.200636682 · Cited by 108
Fuertes, M. B., Girart, M. V., Molinero, L. L., Domaica, C. I., Rossi, L. E., Barrio, M. M., Mordoh, J., Rabinovich, G. A., & Zwirner, N. W. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.7.4606 · Cited by 105
MICA polymorphism: biology and importance in immunity and disease
Choy, M., & Phipps, M. E. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.01.002 · Cited by 118
Rohner, A., Langenkamp, U., Siegler, U., Kalberer, C. P., & Wodnar‐Filipowicz, A. (2007) · Leukemia Research · doi:10.1016/j.leukres.2007.02.020 · Cited by 111
NKG2D CARs as Cell Therapy for Cancer
Sentman, C. L., & Meehan, K. R. (2014) · The Cancer Journal · doi:10.1097/ppo.0000000000000029 · Cited by 106
“Activation of DNA repair mechanisms involving ataxia telangiectasia mutated/ataxia telangiectasia mutated and Rad3-related repair pathways induce ligand expression.(30) Similar mechanisms are likely responsible for the observation that most tumor cells and other cells within the tumor microenvironment express NKG2D li…”
Intestinal Mucosal Inflammation Leads to Systemic Genotoxicity in Mice
Westbrook, A. M., Wei, B., Braun, J., & Schiestl, R. H. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4416 · Cited by 110
“Although the mechanism of this differential induction of apoptosis is uncertain, genotoxic stress induces expression of ligands for the NKG2D receptor (43).”
BackgroundSaikali, P., Antel, J. P., Newcombe, J., Chen, Z., Freedman, M., Blain, M., Cayrol, R., Prat, A., Hall, J. A., & Arbour, N. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4402-06.2007 · Cited by 105
“Pathogens or DNA damage can induce the expression of MICs or ULBPs on different cell types (Groh et al., 2001; Tieng et al., 2002; Welte et al., 2003; Gasser et al., 2005).”
BackgroundGourzi, P., Leonova, T., & Papavasiliou, F. N. (2006) · Immunity · doi:10.1016/j.immuni.2006.03.021 · Cited by 110
“NKG2D ligand upregulation has been linked to activation of the ataxia telangiectasia mutated (ATM) damage checkpoint (Gasser et al., 2005), which eventually inhibits entry of damaged cells into mitosis by activation of the effector kinase Chk1.”
BackgroundInfluentialBedel, R., Thiery-Vuillemin, A., Grandclément, C., Balland, J., Rémy-Martin, J.-P., Kantelip, B. M., Pallandre, J., Pivot, X. B., Ferrand, C., Tiberghien, P., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-09-4540 · Cited by 113
“NKG2D is an activating receptor shared by NK cells and Tcell lymphocytes, now identified as a pivotal mechanism to prevent the emergence of cancer cells arising following DNA damage induction or spontaneous transformation (7, 9, 16).”
An Antitumor Immune Response Is Evoked by Partial-Volume Single-Dose Radiation in 2 Murine Models
Markovsky, E., Budhu, S., Samstein, R. M., Li, H., Russell, J., Zhang, Z., Drill, E. N., Bodden, C., Chen, Q., Powell, S. N., et al. (2018) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2018.10.009 · Cited by 114
Loenhout, J. V., Peeters, M., Bogaerts, A., Smits, E., & Deben, C. (2020) · Antioxidants · doi:10.3390/antiox9121188 · Cited by 114
“Both effects corresponded to increased NK cell-mediated killing of treated tumor cells [96,97].”
BackgroundBeneficial autoimmunity improves cancer prognosis
Zitvogel, L., Perreault, C., Finn, O. J., & Kroemer, G. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00508-x · Cited by 112
Integrating the DNA damage and protein stress responses during cancer development and treatment
Gorgoulis, V. G., Pefani, D., Pateras, I. S., & Trougakos, I. P. (2018) · The Journal of Pathology · doi:10.1002/path.5097 · Cited by 108
“Two of the best characterized connections involve ATM-dependent activation of NEMO, a regulatory subunit of the IKK complex, stimulating NFκΒ activity [356-360], and of NKG2D and DNAM-1/CD226 ligands, two key players of innate imunity [361-363].”
BackgroundActivation and Function of iNKT and MAIT Cells
Chandra, S., & Kronenberg, M. (2015) · Advances in immunology · doi:10.1016/bs.ai.2015.03.003 · Cited by 117
ATM-Mediated Transcriptional and Developmental Responses to γ-rays in Arabidopsis
Ricaud, L., Proux, C., Renou, J., Pichon, O., Fochesato, S., Ortet, P., & Montané, M. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000430 · Cited by 117
“The role of ATM in the self-renewal capacity of hematopoietic stem cells has led to further exploration of other potential ATM-dependent cellular processes such as cell growth, survival, and anti-tumor immune surveillance [22–25].”
BackgroundLee, J. B., Minden, M. D., Chen, W. C., Streck, E., Chen, B., Kang, H., Arruda, A., Ly, D., Der, S. D., Kang, S., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-2228 · Cited by 114
“Expression of NKG2D and DNAM-1 ligands is regulated by the DNA damage repair pathway (47, 48), explaining higher levels of ligand expression on transformed cells (31, 37, 38, 49).”
BackgroundTargeting PARP proteins in acute leukemia: DNA damage response inhibition and therapeutic strategies
Padella, A., di Rorà, A. G. L., Marconi, G., Ghetti, M., Martinelli, G., & Simonetti, G. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01228-0 · Cited by 113
“Further studies linked the HR defects to the signaling downstream ATM, which was impaired in IDH1R132-mutated AML [156].”
BackgroundInfluentialCD8 T Cell Help for Innate Antitumor Immunity
Shanker, A., Verdeil, G., Buferne, M., Inderberg-Suso, E.-M., Puthier, D., Joly, F., Nguyen, C., Leserman, L., Auphan-Anezin, N., & Schmitt-Verhulst, A.-M. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.10.6651 · Cited by 104
“In addition to their activation via disengagement of MHC-recognizing inhibitory receptors (9–11), NK cells have also recently been shown to express stimulatory receptors, such as NKG2D (12).”
BackgroundInfluentialImmunogenic anti-cancer chemotherapy as an emerging concept
Haynes, N. M., der Most, R. G. V., Lake, R., & Smyth, M. J. (2008) · Current Opinion in Immunology · doi:10.1016/j.coi.2008.05.008 · Cited by 114
Methylation of NKG2D ligands contributes to immune system evasion in acute myeloid leukemia
Raneros, A. B., Martín‐Palanco, V., Fernández, A. F., Rodríguez, R. M. A., Fraga, M. F., López‐Larrea, C., & Suárez-Álvarez, B. (2014) · Genes and Immunity · doi:10.1038/gene.2014.58 · Cited by 112
Xu, X., Wang, H., Liu, S., Chen, X., Liu, Y., Aodengqimuge, Zhou, W., Yuan, X., Ma, Y., Hu, M., et al. (2016) · Autophagy · doi:10.1080/15548627.2016.1204496 · Cited by 105
Regulation of NKG2D Ligand Gene Expression
Eagle, R. A., Traherne, J. A., Ashiru, O., Wills, M. R., & Trowsdale, J. (2006) · Human Immunology · doi:10.1016/j.humimm.2006.02.015 · Cited by 117
Selective Induction of Expression of a Ligand for the NKG2D Receptor by Proteasome Inhibitors
Valés-Gómez, M., Chisholm, S. E., Cassady-Cain, R. L., Roda-Navarro, P., & Reyburn, H. T. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2973 · Cited by 96
“This observation is consistent with other data suggesting that the regulation of NKG2D-L expression at the cell surface is a complex process depending on a variety of mechanisms that can act post-transcriptionally and post-translationally (30, 31), as well as at the level of transcription ( 8 ).”
ResultIFN-Dependent Down-Regulation of the NKG2D Ligand H60 on Tumors
Bui, J. D., Carayannopoulos, L. N., Lanier, L. L., Yokoyama, W. M., & Schreiber, R. D. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.2.905 · Cited by 101
“Discussion The signals that induce and/or regulate NKG2D ligand expression on murine tumors are only now being identified, and “stress” is thought to be a common inducing signal (18, 24, 30, 31, 33, 41).”
BackgroundNorman, J. M., Mashiba, M., McNamara, L. A., Onafuwa-Nuga, A., Chiari, E. F., Shen, W., & Collins, K. L. (2011) · Nature Immunology · doi:10.1038/ni.2087 · Cited by 111
NKG2D/NKG2-Ligand Pathway Offers New Opportunities in Cancer Treatment
Frazao, A., Rethacker, L., Messaoudene, M., Avril, M., Toubert, A., Dulphy, N., & Caignard, A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00661 · Cited by 107
“Expression of NKG2D-Ls is induced by DNA damage, a characteristic of tumor transformation, which leads to the activation of the ATM-ATR DNA repair pathways (59).”
BackgroundRegulation of murine NK cell exhaustion through the activation of the DNA damage repair pathway
Álvarez, M., Simonetta, F., Baker, J. B., Pierini, A., Wenokur, A. S., Morrison, A. R., Murphy, W. J., & Negrin, R. S. (2019) · JCI Insight · doi:10.1172/jci.insight.127729 · Cited by 106
“It was reported that inhibition of ATM prevents the expression of stress molecules on tumor cells (26), aphidicolin-treated fibroblasts (26), and antigen-activated T cells (53).”
BackgroundInfluentialThe impact of radiation therapy on the antitumor immunity: Local effects and systemic consequences
Lumniczky, K., & Sáfrány, G. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.08.024 · Cited by 109
“DNA damage response as a consequence of irradiation can upregulate the natural killer group 2, member D (NKG2D) ligands, which act on NK cells and CTLs and stimulate their activation [21].”
BackgroundNatural Killer Cell Signal Integration Balances Synapse Symmetry and Migration
Culley, F. J., Johnson, M. J., Evans, J. H., Kumar, S., Crilly, R., Casasbuenas, J., Schnyder, T., Mehrabi, M., Deonarain, M. P., Ushakov, D. S., et al. (2009) · PLoS Biology · doi:10.1371/journal.pbio.1000159 · Cited by 103
“or UV-induced DNA damage [8,9].”
Fine, J. H., Chen, P., Mesci, A., Allan, D. S. J., Gasser, S., Raulet, D. H., & Carlyle, J. R. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1316 · Cited by 100
Self-citationWhang, M. I., Guerra, N., & Raulet, D. H. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802439 · Cited by 98
“Furthermore, cell surface expression of several different NKG2D ligands, including Rae1, Mult1, and some of the ULBPs, can be enhanced by exposing cultured cells to genotoxic agents (12).”
BackgroundSelf-citationCancer Immunoediting in Malignant Glioma
Dunn, G. P., Fecci, P. E., & Curry, W. T. (2012) · Neurosurgery · doi:10.1227/neu.0b013e31824f840d · Cited by 104
Metadata
- Authors
- Gasser, S., Orsulic, S., Brown, E. J., & Raulet, D. H.
- Affiliations
- University of California, Berkeley (US)
- University of Pennsylvania (US)
- Corresponding author
- Raulet, David H.
- Venue
- Nature
- Published
- 2005-07-03
- Volume
- 436
- Issue
- 7054
- Pages
- 1186-1190
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC1352168
- OpenAlex
- W1969464492
- Cited by
- 1,308
- References
- 28
- Citations by year
- 2026: 23 · 2025: 39 · 2024: 26 · 2023: 51 · 2022: 57 · 2021: 60 · 2020: 72 · 2019: 62 · 2018: 62 · 2017: 64 · 2016: 63 · 2015: 71 · 2014: 85 · 2013: 74 · 2012: 68
- FWCI
- 28.11
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Prostate Cancer Foundation
- National Institutes of Health
- National Cancer Institute (R01CA093678)
- National Institute of Allergy and Infectious Diseases (R01AI039642)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Cell Function and Interaction
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Keywords
- NKG2D, NKG2D ligands, DNA damage response, innate immunity, ATM kinase, ATR kinase, Chk1, genotoxic stress, natural killer cells, CD8+ T cells, cancer cell lines, siRNA
- MeSH terms
- Checkpoint Kinase 1, Animals, Cell Transformation, Neoplastic, DNA Damage, DNA Replication, Fibroblasts, Humans, Immune System, Immunity, Innate, Kinetics, Ligands, Mice, Inbred C57BL, Phosphorylation, Protein Kinases, Receptors, Immunologic, Up-Regulation, Aphidicolin, Protein Serine-Threonine Kinases, Cell Cycle Proteins, Cell Line, Tumor, Mice, Receptors, Natural Killer Cell, NK Cell Lectin-Like Receptor Subfamily K, Ataxia Telangiectasia Mutated Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.